SCH2-1-20

N/A

Report date: 2022/01/05 15:24:33
NME

Base Information

Drug NameSCH2-1-20
Drug Alias NameSCH2-1-20
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCoronavirus spike glycoprotein inhibitors
TargetsCoronavirus spike glycoprotein
Therapy Area/IndicationsCoronavirus Disease 2019 (COVID-19)
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesSecond Military Medical University Of Chinese People'S Liberation Army
China Registration ClassN/A

Develop Information

Active CompaniesSecond Military Medical University Of Chinese People'S Liberation Army
Inactive CompaniesN/A
Active IndicationsCoronavirus Disease 2019 (COVID-19)
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A